Summary
High frequencies of loss of heterozygosity (LOH) in chromosome 11q22-qter have been observed in various malignancies, including breast cancer. Previous studies on breast carcinomas by Winqvist et al (Cancer Res 55: 2660–2664) have indicated that a survival factor gene is located in band 11q23, and that the highly informative microsatellite polymorphism at the APOC3 locus would be a suitable tool to perform more extensive LOH studies. In this European multicentre study, we have examined the occurrence of APOC3 LOH and evaluated the effect of LOH of this chromosomal subregion on the clinical behaviour of the disease in a cohort of 766 breast cancer patients in more detail. LOH for APOC3 was found in 42% of the studied tumours, but it was not found to be significantly associated with any of the studied clinical variables, including cancer-specific survival time or survival time after recurrent/metastatic disease. According to the present findings, the putative survival factor gene on 11q23 is not located close enough to the APOC3 gene, but apparently at a more proximal location.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Arai, Y., Hosoda, F., Nakayama, K. & Ohki, M. (1996). A yeast artificial chromosome contig and NotI restriction map that spans the tumor suppressor gene(s) locus, 11q22.2–q23.3. Genomics 35: 196–206.
Bhattacharya, S., Wilson, T. M. E., Wojciechowski, A. P., Volpe, C. P. & Scott, J. (1991). Hypervariable polymorphism in the APOC3 gene. Nucleic Acids Res 17: 4799
Bièche, I. & Lidereau, R. (1995). Genetic alterations in breast cancer. Genes Chromosomes Cancer 14: 227–251.
Furnari, B., Rhind, N. & Russell, P. (1997). Cdc25 mitotic inducer targeted by Chk1 DNA damage checkpoint kinase. Science 277: 1495–1497.
Gabra, H., Watson, J. E. V., Taylor, K. J., Mackay, J., Leonard, R. C. F., Steel, C. M., Porteous, D. J. & Smyth, J. F. (1996). Definition and refinement of a region of loss of heterozygosity at 11q23.3–q24.3 in epithelial ovarian cancer associated with poor prognosis. Cancer Res 56: 950–954.
Gudmundsson, J., Barkardottir, R. B., Eiriksdottir, G., Baldursson, T., Arason, A., Egilsson, V. & Ingvarsson, S. (1995). Loss of heterozygosity at chromosome 11 in breast cancer: association of prognostic factors with genetic alterations. Br J Cancer 72: 696–701.
Hampton, G. M., Mannermaa, A., Winqvist, R., Alavaikko, M., Blanco, G., Taskinen, P. J., Kiviniemi, H., Newsham, I., Cavenee, W. K. & Evans, G. A. (1994). Loss of heterozygosity in sporadic human breast carcinoma: a common region between 11q22 and 11q23.3. Cancer Res 54: 4586–4589.
Herbst, R. A., Larson, A., Weiss, J., Cavenee, W. K., Hampton, G. M. & Arden, K. C. (1995). A defined region of loss of heterozygosity a 11q23 cutaneus malignant melanoma. Cancer Res 55: 2494–2496.
Hui, A. B. Y., Lo, K-W, Leung, S-F, Choi, P. H. K., Fong, Y., Lee, J. C. K. & Huang, D. P. (1996). Loss of heterozygosity on the long arm of chromosome 11 in nasopharyngeal carcinoma. Cancer Res 56: 3225–3229.
Kerangueven, F., Eisinger, F., Noguchi, T., Allione, F., Wargniez, V., Eng, C., Padberg, G., Theillet, C., Jacquemier, J., Longy, M., Sobol, H. & Birmbaum, D. (1997). Loss of heterozygosity in human breast carcinomas in the ataxia telangiectasia, Cowden disease and BRCAI gene regions. Oncogene 14: 339–347.
Laake, K., Ødegård, Å, Andersen, T. I., Bukholm, I. K., Kåresen, R., Nesland, J. M., Ottestad, L., Shiloh, Y. & Børresen-Dale, A-L (1997). Loss of heterozygosity at 11q23.1 in breast carcinomas: indication for involvement of a gene distal and close to ATM. Genes Chromosom Cancer 18: 175–180.
Lindblom, A., Sandelin, K., Iselius, L., Dumanski, J., White, I., Nordenskjöld, M. & Larsson, C. (1994). Predisposition for breast cancer in carriers of constitutional translocation 11q;22q. Am J Hum Genet 54: 871–876.
Monaco, C., Negrini, M., Sozzi, G., Veronese, M. L., Vorechovsky, I., Godwin, A. K. & Croce, C. M. (1997). Molecular cloning and characterization of LOH11CR2A, a new gene within a refined minimal region of LOH at 11q23. Genomics 46: 217–222.
Negrini, M., Sabbioni, S., Possati, L., Rattan, S., Corallini, A., Barbanti–Brodano, G. & Croce, C. M. (1994). Suppression of tumorigenicity of breast cancer cells by microcell-mediated chromosome transfer: studies on chromosomes 6 and 11. Cancer Res 54: 1331–1336.
Negrini, M., Rasio, D., Hampton, G. M., Sabbioni, S., Rattan, S., Carter, S. L., Rosenberg, A. L., Schwartz, G. F., Shiloh, Y., Cavenee, W. K. & Croce, C. M. (1995). Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3. Cancer Res 55: 3003–3007.
Phillips, K. K., Welch, D. R., Miele, M. E., Lee, J-H, Wei, L. L. & Weissman, B. E. (1996). Suppression of MDA- MB-435 breast carcinoma cell metastasis following the introduction of human chromosome 11. Cancer 56: 1222–1227.
Rasio, D., Negrini, M., Manenti, G., Dragani, T. A. & Croce, C. M. (1995). Loss of heterozygosity at chromosome 11q in lung adenocarcinoma: identification of three independent regions. Cancer Res 55: 3988–3991.
Robertson, G., Coleman, A. & Lugo, T. G. (1996). A malignant melanoma tumor suppressor on human chromosome 11. Cancer Res 56: 4487–4492.
Sanchez, Y., Wong, C., Thoma, R. S., Richman, R., Wu, Z., Piwnica-Worms, H. & Elledge, S. J. (1997). Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science 277: 1497–1501.
Sarkar, G. (1995). PCR in Neuroscience, pp. 168–169. Academic Press: New York
Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Stez, S., Ashkenazi, M., Pecker, I., Frydman, M., Harnik, R., Patanjali, S. R., Simmons, A., Clines, G. A., Sartiel, A., Gatti, R. A., Chessa, L., Sanal, O., Lavin, M. F., Jaspers, N. G. J., Taylor, A. M. R., Arlett, C. F., Miki, T., Weissman, S. M., Lovett, M., Collins, F. S. & Shiloh, Y. (1995). A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268: 1749–1753.
Savitsky, K., Ziv, Y., Bar–Shira, A., Gilad, S., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., Nahmias, J., Sartiel, A., Eddy, R. L., Shows, T. B., Collins, F. S., Shiloh, Y. & Rotman, G. (1996). A human gene (DDX10) encoding a putative DEAD-box RNA helicase at 11q22-q23. Genomics 33: 199–206.
Winqvist, R., Hampton, G. M., Mannermaa, A., Blanco, G., Alavaikko, M., Kiviniemi, H., Taskinen, P. J., Evans, G. A., Wright, F. A., Newsham, I. & Cavenee, W. K. (1995). Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis. Cancer Res 55: 2660–2664.
Ziemin-van der Poel, S., McCable, N. R., Gill, H. J., Espinosa, III R., Patel, Y., Harden, A., Rubinelli, P., Smith, S. D., LeBeau, M. M., Rowley, J. D. & Diaz, M. O. (1991). Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. Proc Natl Acad Sci USA 88: 10735–10739.
Author information
Authors and Affiliations
Consortia
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Launonen, V., Laake, K., Huusko, P. et al. European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables. Br J Cancer 80, 879–882 (1999). https://doi.org/10.1038/sj.bjc.6690435
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690435